Novel Drug Has Dual Action in Asthma, COPD

A novel inhaled drug appeared safe as a dual bronchodilator and anti-inflammatory in asthma and chronic obstructive pulmonary disease (COPD), a series of proof-of-concept studies showed. In COPD patients, nebulized RPL554 boosted forced expiratory volume in 1 second (FEV1) by 17% versus placebo, with peak effects comparable to inhaled beta-2 agonists, Clive P. Page, PhD,Continue reading “Novel Drug Has Dual Action in Asthma, COPD”

COPD telemonitoring ‘costly and ineffective’

BMJ 2013; 347: f5932 Results of a UK-based study indicate that telemonitoring adds little benefit to the self-management of chronic obstructive pulmonary disease (COPD). Hilary Pinnock (University of Edinburgh, UK) and colleagues randomly assigned 128 primary care patients with a history of COPD admission to undergo telemonitoring, and 128 to receive usual care, including self-monitoring.Continue reading “COPD telemonitoring ‘costly and ineffective’”